Sign In | Create an Account | Welcome, . My Account | Logout | Subscribe | Submit News | Affiliated Sites | All Access E-Edition | Home RSS

FDA questions Amgen drug used for prostate cancer

February 14, 2012
By MATTHEW PERRONE - AP Health Writer , The Mining Journal

WASHINGTON - Scientists for the Food and Drug Administration say that an Amgen drug slowed the spread of cancer to the bone in men with hard-to-treat prostate cancer, though the drug did not extend life and carried significant side effects.



I am looking for:
News, Blogs & Events Web